Medtronic, a global leader in healthcare technology, today announced it has entered into a strategic partnership agreement with CathWorks.
Our partnership with Medtronic underscores their commitment to investing in innovative technologies that support physicians and patients from diagnosis to treatment and CathWorks’ FFRangio® System’s potential to disrupt traditional FFR and revolutionize the management of coronary artery disease.